Trial no.:
|
PACTR201512000952372 |
Date of Approval:
|
30/11/2014 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
hCG luteal support after Triptorelin trigger in IVF |
Official scientific title |
Does hCG Luteal Support Improve Pregnancy Rates in IVF Cycles with Cetrorelix Down-regulation and Triptorelin Triggering? |
Brief summary describing the background
and objectives of the trial
|
Patients undergoing IVF cycles using the antagonist protocol (e.g. Cetrorelix) could receive Triptorelin as a trigger injection to reduce the incidence of ovarian hyper-stimulation syndrome (OHSS). This could possibly decrease pregnancy rates. Luteal phase support using hCG could, however, improve pregnancy rates on the expense of higher incidence of OHSS. No RCT until now has addressed this issue. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Infertility,Obstetrics and Gynecology,Pregnancy and Childbirth |
Sub-Disease(s) or condition(s) being studied |
Fertility-female |
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
01/12/2014 |
Actual trial start date |
01/12/2014 |
Anticipated date of last follow up |
01/06/2015 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
170 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|